Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib
Hazem El-Osta,1 Rodney Shackelford2 1Department of Medicine, 2Department of Pathology, Feist-Weiller Cancer Center, Louisiana State University Health Science Center-Shreveport, Shreveport, LA, USA Abstract: The fusion of echinoderm microtubule-associated protein-like 4 with the anaplastic lymphoma...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-09-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Online Access: | https://www.dovepress.com/personalized-treatment-options-for-alk-positive-metastatic-non-small-c-peer-reviewed-article-PGPM |